DK0524421T3 - Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse - Google Patents

Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse

Info

Publication number
DK0524421T3
DK0524421T3 DK92110047T DK92110047T DK0524421T3 DK 0524421 T3 DK0524421 T3 DK 0524421T3 DK 92110047 T DK92110047 T DK 92110047T DK 92110047 T DK92110047 T DK 92110047T DK 0524421 T3 DK0524421 T3 DK 0524421T3
Authority
DK
Denmark
Prior art keywords
dna sequences
corresponding dna
protein
preparation
virus type
Prior art date
Application number
DK92110047T
Other languages
Danish (da)
English (en)
Inventor
Frank Neipel
Bernhard Fleckenstein
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of DK0524421T3 publication Critical patent/DK0524421T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DK92110047T 1991-07-08 1992-06-15 Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse DK0524421T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91111338 1991-07-08

Publications (1)

Publication Number Publication Date
DK0524421T3 true DK0524421T3 (da) 2003-07-21

Family

ID=8206915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92110047T DK0524421T3 (da) 1991-07-08 1992-06-15 Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse

Country Status (10)

Country Link
US (3) US5814475A (de)
EP (1) EP0524421B1 (de)
JP (1) JP3425164B2 (de)
AT (1) ATE235553T1 (de)
AU (1) AU666482B2 (de)
CA (1) CA2073282C (de)
DE (1) DE69232975T2 (de)
DK (1) DK0524421T3 (de)
ES (1) ES2194008T3 (de)
PT (1) PT524421E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4795993A (en) * 1992-07-31 1994-03-03 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for detecting human herpesvirus 6 strain z29
DE59710091D1 (de) 1997-07-11 2003-06-18 Fleckenstein Bernard Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
SE528319C2 (sv) * 2004-09-17 2006-10-17 Forskarpatent I Syd Ab Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn
WO2007103988A2 (en) * 2006-03-08 2007-09-13 University Of Rochester Compositions and methods for detection and treatment of human herpesvirus (hhv)-6

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013536A1 (de) * 1989-05-04 1990-11-08 Univ Kansas Monoclonaler antikoerper fuer mit hhv-6 infizierte zellen und deren proteinmaterial sowie seine anwendungen
FR2651007B1 (fr) * 1989-08-18 1992-09-04 Pasteur Institut Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procede de diagnostic des infections a hhv6
DE4013526C2 (de) * 1990-04-27 1994-04-28 Rutenbeck Wilhelm Gmbh & Co Schaltungsanordnung zum Übertragen von Daten zwischen mehreren Geräten über eine Busleitung

Also Published As

Publication number Publication date
US6174685B1 (en) 2001-01-16
US5814475A (en) 1998-09-29
US5827519A (en) 1998-10-27
AU666482B2 (en) 1996-02-15
EP0524421B1 (de) 2003-03-26
ES2194008T3 (es) 2003-11-16
DE69232975T2 (de) 2004-03-04
CA2073282C (en) 2005-12-06
PT524421E (pt) 2003-08-29
CA2073282A1 (en) 1993-01-09
ATE235553T1 (de) 2003-04-15
JP3425164B2 (ja) 2003-07-07
EP0524421A1 (de) 1993-01-27
AU1945592A (en) 1993-01-14
JPH06113858A (ja) 1994-04-26
DE69232975D1 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
AU2196592A (en) Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
CA2113712A1 (en) Papilloma virus vaccine
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
EP1757697A3 (de) Gruppe B-Streptococcus Antigene
GB2255093A (en) Hiv-1 core protein fragments
DE68929545D1 (de) Pollen Allergene
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
EP1297147B8 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
EP0306219A3 (de) HIV-Proteine und Peptide zur Verwendung in Diagnose, Prophylaxe und Therapie von AIDS
HK1046648B (zh) 包括最少兩個不同變應原蛋白的含雜種多肽疫苗
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
DE60026588D1 (de) Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
OA09653A (en) Rubella peptides
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DK0588177T3 (da) Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet
GB9810084D0 (en) Proteins
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
WO1992001794A3 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung
SE9604439D0 (sv) New receptor
BR1100801A (pt) Proteìna, peptìdeo, proteìna ou peptìdeo, sequência de dna, processo para a preparação de uma proteìna ou peptìdeo, anticorpo, composição farmacêutica, e, uso de uma proteìna ou peptìdeo